GIVE MISS CALL ON :- +91 99774 99927

TOP CORPORATE NEWS- 25 MAR 2019

Varun Beverages gets CCI nod for acquisition of franchise rights from PepsiCo India Varun Beverages received approval from the Competition Commission of India (CCI) for the proposed acquisition of franchise rights in South and West regions from PepsiCo India Holding. Despite this, shares of the company were trading 0.5% down on Monday. The company had

CAPITALSTARS INDIAN EQUITY MARKET WRAP UP – 25 MAR 2019

Closing Bell: Nifty ends around 11,350, Sensex falls 355 points; ONGC gains 4%. Benchmark indices ended lower as they remained under pressure throughout on Monday with Nifty finished around 11,350 mark. At the close, the Sensex was down 355.70 points at 37,808.91, while Nifty was down 102.60 points at 11,354.30. About 812 shares have advanced,

CAPITALSTARS – MCX COMMODITY MARKET LEVELS – 25 MAR 2019

Precious Metals Preview: COMEX Gold Well Supported. COMEX Gold futures were supported last week. The metal surged to a four week high following the boost provided by the US Fed’s dovish stance. Gold gained after the US Federal Reserve said that the United States economy was slowing more than it had previously thought. The Fed

CAPITALSTARS – MCX COMMODITY MORNING MARKET NEWS UPDATES GOLD PRICES FIRMED ON MONDAY – 25 MARCH 2019

BULLION – Bullion counter may trade with positive bias. Gold prices firmed on Monday as concerns about a potential U.S. recession and decelerating global growth weighed on stock markets, which increased appetite for safer assets. Investors dumped shares on Monday and fled to the safety of bonds, while the Japanese yen hovered near a six-week

CAPITALSTARS- INDIAN EQUITY MARKET OUTLOOK – 25 MAR 2019

Market Live: Nifty likely to open lower. The Nifty50 is likely to open lower on Monday following muted trend seen in other Asian markets. The index closed 64 points lower at 11,456 on Friday. Trends on SGX Nifty indicate a negative opening for the broader index in India, a fall of 59 points or 0.51

TOP CORPORATE NEWS- 22 MAR 2019

Cadila says no observation by USFDA on Ahmedabad R&D facility Shares of Cadila Healthcare slipped 2% in the last hour of the trading session on the BSE. “USFDA inspected the Pharmaceutical Technology Centre (PTC), the company’s state-of-the-art R&D facility located at Ahmedabad, dedicated to new product development of various niche dosage forms including solid oral,

Checking...

Ouch! There was a server error.
Retry »

Sending message...

FREE TRIAL REQUEST


CapitalStars FORUM